We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
KLA
KLAC
$253B
| $2.2M | 0.01% |
67,890
-404,070
| -86% | -$12.9M |
|
777
International Paper
IP
$21.8B
| $2.18M | 0.01% |
37,598
-163,197
| -81% | -$9.32M |
|
778
Mesa Laboratories
MLAB
$570M
| $2.17M | 0.01% |
7,990
+136
| +2% | +$34.5K |
|
779
Procore
PCOR
$8.84B
| $2.16M | 0.01% |
+22,727
| New | +$1.99M |
|
780
Enphase Energy
ENPH
$5.46B
| $2.15M | 0.01% |
11,705
-2,225
| -16% | -$326K |
|
781
TE Connectivity
TEL
$62.6B
| $2.14M | 0.01% |
15,828
-246,147
| -94% | -$33M |
|
782
Citi Trends
CTRN
$624M
| $2.14M | 0.01% |
+24,563
| New | +$2.26M |
|
|
KNBE
783
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $2.14M | 0.01% |
+68,321
| New | +$1.56M |
|
784
Blue Owl Capital
OBDC
$5.65B
| $2.13M | 0.01% |
149,455
-324,640
| -68% | -$4.67M |
|
|
CFLT
785
DELISTED
Confluent
CFLT
| $2.13M | 0.01% |
+44,852
| New | +$2.17M |
|
786
Gibraltar Industries
ROCK
$1.45B
| $2.13M | 0.01% |
27,867
+3,576
| +15% | +$296K |
|
787
Pinduoduo
PDD
$132B
| $2.13M | 0.01% |
16,733
+6,507
| +64% | +$846K |
|
788
Baxter International
BAX
$14.4B
| $2.12M | 0.01% |
+26,324
| New | +$2.21M |
|
789
monday.com
MNDY
$3.68B
| $2.12M | 0.01% |
+9,461
| New | +$2.06M |
|
|
SWBK
790
DELISTED
Switchback II Corporation
SWBK
| $2.11M | 0.01% |
213,645
| – | – |
|
791
Las Vegas Sands
LVS
$29.5B
| $2.1M | 0.01% |
39,966
-47,174
| -54% | -$2.72M |
|
792
Magna International
MGA
$18.8B
| $2.08M | 0.01% |
22,472
-198,425
| -90% | -$18.9M |
|
|
EVA
793
DELISTED
Enviva Inc.
EVA
| $2.08M | 0.01% |
39,723
+14,383
| +57% | +$709K |
|
794
AGNC Investment
AGNC
$12.6B
| $2.08M | 0.01% |
+123,080
| New | +$2.19M |
|
795
Amneal Pharmaceuticals
AMRX
$5.78B
| $2.06M | 0.01% |
402,449
-82,329
| -17% | -$468K |
|
796
Ironwood Pharmaceuticals
IRWD
$673M
| $2.05M | 0.01% |
159,157
+84,047
| +112% | +$962K |
|
|
VMEO
797
DELISTED
Vimeo
VMEO
| $2.04M | 0.01% |
+41,564
| New | +$1.91M |
|
798
Sonos
SONO
$1.86B
| $2.02M | 0.01% |
57,365
-54,231
| -49% | -$2.03M |
|
|
JHG
799
DELISTED
Janus Henderson
JHG
| $2.02M | 0.01% |
51,951
-743,450
| -93% | -$27M |
|
|
ATSG
800
DELISTED
Air Transport Services Group
ATSG
| $2.01M | 0.01% |
+86,730
| New | +$2.25M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.